Phase 1
N=3
A BCT Intervention for Physical Activity Among Individuals on Statins
Insufficient Physical Activity
Bottom Line
View on ClinicalTrials.gov: NCT05273723 ↗Enrolled (actual)
3
Serious AEs
0.0%
Results posted
Dec 2024
Primary outcome: Primary: Number of Participants Who Achieved a 2,000 Step/Day Increase Between run-in and Follow-up — 7 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 1
- Interventions
- 5 Behavioral Change Techniques (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Northwell Health
- Primary completion
- Jul 2023
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants Who Achieved a 2,000 Step/Day Increase Between run-in and Follow-up |
7 | — |
| SECONDARY Within-person Change in Daily Steps. |
-152.23 | — |
| SECONDARY Within-person Change in Self-Efficacy for Walking. |
18.87 | — |
| SECONDARY Within-person Change in Intrinsic Regulation. |
0.292 | — |
| SECONDARY Within-person Change in Discrepancy in Behavior. |
-1.13 | — |
| SECONDARY Within-person Change in Motivation. |
0.167 | — |
| SECONDARY Within-person Change in Environmental Context and Resources. |
0.176 | — |
| SECONDARY Within-person Change in Medication Adherence. |
-0.16 | — |
Summary
The purpose of this project is to identify the minimum effective dose (MED) of a multi-component behavioral change intervention required to increase levels of physical activity (PA) among participants on primary prevention statin therapy who are at elevated risk for cardiovascular disease (CVD). The intervention will be comprised of 5 BCTs which have previously shown to be effective on increasing health behaviors: Goal Setting, Action Planning, Self-Monitoring, Feedback, and Prompts/Cues. Participants will complete a 2-week baseline run-in period where PA levels will be measured using Fitbit wearable device. Then 42 participants will be randomized into 14 cohorts of 3 participants each for the intervention period. During the intervention period, participants will receive a multi-BCT intervention, the length of which varies between 1 and 10 weeks depending on the assigned dose. Assignment to doses will utilize a modified version of the Time-to-Event Continual Reassessment Method (TiTE-CRM) methodology to adjust the dose for each cohort based on the results from the previous cohort. After the intervention, there will be a 2-week follow-up period. The MED will be defined as the smallest BCT dose (defined by weeks of intervention) associated with 80% of participants having a successful PA increase between the run-in and the follow-up periods (defined as walking an extra 2,000 more steps per day).
Eligibility Criteria
Inclusion Criteria
- Ages 18 or older;
- Northwell Health employee/affiliate
- Ambulatory without limitations: has never been advised by a clinician that increasing low-intensity walking would be unsafe;
- Prescribed statin medication;
- Self-reported low levels of physical activity
- Access to and capable of using a smart cellular phone;
- After 2 week run-in, objectively-verified low levels of physical activity as documented by a commercially available Fitbit device
- English speaking.
Exclusion Criteria
- Age less than 18 years;
- Not a Northwell Health employee/affiliate
- Non-ambulatory or unsafe/not recommended to participate in a walking program
- Not prescribed statin medication;
- History of CVD;
- Inability to comply with study protocol during 2 week run-in;
- Does not speak English;
- Unavailable for follow-up;
- Cognitive impairment;
- Severe mental illness (e.g., bipolar disorder or schizophrenia);
- Pregnancy
Data sourced from ClinicalTrials.gov (NCT05273723). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.